These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 31513035)

  • 21. Buprenorphine Provision by Early Career Family Physicians.
    Tong ST; Hochheimer CJ; Peterson LE; Krist AH
    Ann Fam Med; 2018 Sep; 16(5):443-446. PubMed ID: 30201642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends In Buprenorphine Prescribing By Physician Specialty.
    Wen H; Borders TF; Cummings JR
    Health Aff (Millwood); 2019 Jan; 38(1):24-28. PubMed ID: 30615523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid Use Disorder and Pregnancy.
    O'Donnell FT; Jackson DL
    Mo Med; 2017; 114(3):181-186. PubMed ID: 30228577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Buprenorphine prescribing by APRNs.
    Rundio A
    J Addict Nurs; 2012 Feb; 23(1):80-1. PubMed ID: 22468666
    [No Abstract]   [Full Text] [Related]  

  • 25. Beyond state scope of practice laws for advanced practitioners: Additional supervision requirements for buprenorphine prescribing.
    Andraka-Christou B; Gordon AJ; Spetz J; Totaram R; Golan M; Randall-Kosich O; Harrison J; Calder S; Kertesz SG; Stein BD
    J Subst Abuse Treat; 2022 Jul; 138():108715. PubMed ID: 35067400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults.
    Cottrill CB; Matson SC
    Adolesc Med State Art Rev; 2014 Aug; 25(2):251-65. PubMed ID: 27132312
    [No Abstract]   [Full Text] [Related]  

  • 27. A New Way Forward in the Emergency Department.
    Schwarz ES; Laes JR; Wiegand TJ
    J Med Toxicol; 2019 Oct; 15(4):220-222. PubMed ID: 31278586
    [No Abstract]   [Full Text] [Related]  

  • 28. Rapid upscale of depot buprenorphine (CAM2038) in custodial settings during the early COVID-19 pandemic in New South Wales, Australia.
    Roberts J; White B; Attalla D; Ward S; Dunlop AJ
    Addiction; 2021 Feb; 116(2):426-427. PubMed ID: 32888226
    [No Abstract]   [Full Text] [Related]  

  • 29. Removing One Barrier to Opioid Use Disorder Treatment: Is It Enough?
    Weimer MB; Wakeman SE; Saitz R
    JAMA; 2021 Mar; 325(12):1147-1148. PubMed ID: 33630020
    [No Abstract]   [Full Text] [Related]  

  • 30. Increases in Providers With Buprenorphine Waivers in the United States From 2016 to 2019.
    Ghertner R; Ali MM
    Psychiatr Serv; 2020 Sep; 71(9):971. PubMed ID: 32460681
    [No Abstract]   [Full Text] [Related]  

  • 31. Patients With Opioid Use Disorder Deserve Trained Providers.
    Weimer MB; Tetrault JM; Fiellin DA
    Ann Intern Med; 2019 Dec; 171(12):931-932. PubMed ID: 31766053
    [No Abstract]   [Full Text] [Related]  

  • 32. Buprenorphine offers a way to rise from the ashes of addiction.
    Newcomb A
    J Fam Pract; 2021 Sep; 70(7):317. PubMed ID: 34818160
    [No Abstract]   [Full Text] [Related]  

  • 33. Family Physicians Play Key Role in Bridging the Gap in Access to Opioid Use Disorder Treatment.
    Abraham R; Wilkinson E; Jabbarpour Y; Bazemore A
    Am Fam Physician; 2020 Jul; 102(1):10. PubMed ID: 32603069
    [No Abstract]   [Full Text] [Related]  

  • 34. Home Induction of Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy.
    Kelly JC; Raghuraman N; Stout MJ; Russell S; Perez M; Nazeer S; El Helou N; Zhang F; Carter E
    Obstet Gynecol; 2021 Oct; 138(4):655-659. PubMed ID: 34623078
    [No Abstract]   [Full Text] [Related]  

  • 35. The Number Needed to Prescribe - What Would It Take to Expand Access to Buprenorphine?
    Poorman E
    N Engl J Med; 2021 May; 384(19):1783-1784. PubMed ID: 33983689
    [No Abstract]   [Full Text] [Related]  

  • 36. The disparate treatment of medications and opiate pain medications under the law: permitting the proliferation of opiates and limiting access to treatment.
    Ferrara MM
    Seton Hall Law Rev; 2012; 42(2):741-67. PubMed ID: 22708140
    [No Abstract]   [Full Text] [Related]  

  • 37. Non-buprenorphine opioid utilization among patients using buprenorphine.
    Daubresse M; Saloner B; Pollack HA; Alexander GC
    Addiction; 2017 Jun; 112(6):1045-1053. PubMed ID: 28107580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Provider and patient perspectives on barriers to buprenorphine adherence and the acceptability of video directly observed therapy to enhance adherence.
    Godersky ME; Saxon AJ; Merrill JO; Samet JH; Simoni JM; Tsui JI
    Addict Sci Clin Pract; 2019 Mar; 14(1):11. PubMed ID: 30867068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Long-Acting Buprenorphine Medications for Opioid Dependence: Current Update.
    Soyka M
    Pharmacopsychiatry; 2021 Jan; 54(1):18-22. PubMed ID: 33212514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deploying science to change hearts and minds: Responding to the opioid crisis.
    Walsh SL; Long KQX
    Prev Med; 2019 Nov; 128():105780. PubMed ID: 31319116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.